Motivation: Using bioinformatic approaches we aimed to characterize poorly-understood abnormalities in splicing known as exon scrambling, exon repetition, and trans-splicing.
INTRODUCTION
Excision of introns from pre-mRNA is a complex process in which several types of small nuclear RNAs and several dozens of proteins assemble into a spliceosomal complex (Maniatis and Reed 2002) . The precise recognition of exon-intron junctions by a spliceosome is crucial for the production of functional mRNAs. However, there is often ambiguity in the choice of exon-intron junctions. This results in a process known as alternative splicing, which occurs in approximately 50% of mammalian genes and enables production of multiple mRNA isoforms from the same gene, often in a tissuespecific or development-stage-specific manner (Modrek and Lee 2002; Stamm 2002) .
There are three other types of splicing-associated peculiarities reported to result in abnormal exon arrangement within mRNA molecules. The first of these is called exon repetition (ExRep) and was first characterized by Caudevilla et al. (1998) . These studies showed that two copies of exon 2, from the rat carnitine octanoyltransferase gene, were positioned adjacent to one another in some mRNAs while the genomic sequence contained only a single copy. ExRep has been further described in other genes of vertebrates (Frantz et al. 1999; Finta and Zaphiropoulos 2000; Hide et al. 2001; Rigatti et al. 2004) . A second form of abnormal exon arrangement is exon scrambling (ExScram) and was first described by Nigro and co-authors (Nigro et al. 1991) , in which some products of the human tumor suppressor gene DCC had an aberrant order of exons. For example, in some DCC mRNA molecules they found that exon 4 preceded exon 2, while in other mRNAs exon 4 preceded exon 3. This exon arrangement could not be explained by alternative splicing, and thus, this process was identified as scrambling (perhaps resulting from circular mRNAs). Other cases of ExScram were described thereafter by others (Cocquerelle et al. 1993; Zaphiropoulos 1996; Zaphiropoulos 1997; Caldas et al. 1998; Crawford et al. 1999; Takahara et al. 2000; Flouriot et al. 2002) . Third is a process known as trans-splicing (TransSpl), in which transcripts from two different genes are joined at a splicing junction (Bonen 1993) . Trans-splicing is widespread in some protozoa (such as trypanosomes) and in nematodes, where a common 5' leader sequence on mRNAs is the result. TransSpl has also been described in Drosophila (Dorn et al. 2001) , rodents (Caudevilla et al. 2001; Hirano and Noda 2004) , and human (Takahara et al. 2000; Li et al. 1999; Akopian et al. 1999) .
While ExRep, ExScram have been studied for a decade, no systematic statistical assessment has been done yet to estimate the prevalence of these phenomena, or to provide clues as to their physiological bases. TransSpl has been computationally analyzed by Romani et al. on a dataset of human mRNAs (2003) . Modern sequencing techniques have resulted in the characterization of hundreds of thousands of genes and millions of mRNA products. Such efforts have facilitated the investigation of biological processes in silico by computer examination of nucleotide sequence databases. The most important source of data for computational analysis of splicing is the Expressed Sequence Tag (EST) database (Boguski et al. 1993) . Recently, analyses of EST data demonstrated that at least 50% of human genes produce alternative isoforms (Modrek and Lee 2002) . The current release of the human EST database contains sequences of over six million mRNA fragments. Therefore, on average, each human gene is represented by >200 different ESTs. Here, we present a program package to study ExRep, ExScram, and TransSpl in silico by comparison of the EST database with the database of their native gene sequences. We have applied our programs to examine six million human EST sequences, and report here 742 ESTs having sequences consistent with ExRep, ExScram, or TransSpl. Our results suggest that a small subset of ExRep cases (2-3%) may have a physiological basis, while the other apparent examples of these three splicing variations may be artifactual.
MATERIALS AND METHODS

Databases
Human genomic sequences were obtained from GenBank, Build 35.1. After processing this database with the Exon-Intron Database (EID) toolkit (Saxonov et al. 2000) , a comprehensive collection of human gene, mRNA, and individual exon and intron sequences was obtained based on annotations in GenBank. This secondary database (human genome EID) is publicly available from our EID website http://www.meduohio.edu/bioinfo/eid/ (file hs35p1.EID.tar.gz), and is accompanied with a description of the database (see README file at http://www.meduohio.edu/bioinfo/eid/word/README_Sept05.DOC). The advantages to using EID in our project include a convenient representation of exon/intron gene structures and availability of each gene sequence together with the related sequences of its mRNA, exons, and introns that share a common EID identifier. The order of genes in EID strictly follows that of GenBank, and therefore corresponds to the physical order of genes in chromosomes. Several programs within the EID toolkit check the original input database and report possible errors and problems with primary sources.
Human EST sequences were obtained from GenBank, release 138 (Benson et al. 1999) . This dataset contains nearly 19 million EST sequences from numerous organisms (GenBank files gbestN.seq, where N is 1 to 279). An in-house Perl-script was used to select human ESTs (5,987,567 sequences) from the original dataset. All of these human ESTs were used in our analysis without additional filtering.
Description of sequence comparison algorithms
For fast comparison of millions of sequences on a workstation (Athlon 2200+ CPU) with a large Random Access Memory capacity (4 GB RAM), we did not use standard alignment programs, but instead chose an alternative approach to direct matching of short sequence fragments. Each human mRNA sequence was divided into overlapping 28 nucleotide-long fragments (step size of 1 nt) that were stored in the very large associative array (Perl hash). The oligonucleotide sequences were the keys in this array and the mRNA identifiers were the values. Having all these oligonucleotides of all human mRNA sequences in the memory, allowed us to immediately assign each EST sequence to its native mRNA sequence. For this purpose, each EST sequence was scanned with a 28-nt window using a step size of one nucleotide and the associative array showed which gene(s) the current EST fragment belongs to. Often, poor quality of EST 5`-and 3`-ends make EST to gene correspondence difficult to establish. Since we used all possible 28-nt windows for each EST, the better quality EST regions compensated for this problem, and made possible the EST to mRNA correspondence. After initial screening with this approach, the final subsets of EST candidates for ExRep, ExScram, and TransSpl were aligned with their genes using BLAST. We have successfully utilized this computational approach in several large-scale projects and it is our policy to make this software publicly available from our website.
Programs for computations of ExRep, ExScram, and TransSpl
SCRAMBLING package represents a pipeline of programs written in PERL that are available from our web-page http://www.meduohio.edu/bioinfo/software.html. The algorithms underlying these programs are described in the Results and Discussion section. Among these programs ESR1.pl and ESR2.pl scripts perform large-scale comparisons of ESTs with all human mRNA sequences. Program ESR3.pl maps EST ends on the corresponding mRNA and calculates the lengths of EST and the mRNA fragment. Programs ESR4.pl and ESR5.pl compare EST and exon sequences for calculation of exon representation score and exon order within EST respectively. Program ESR6.pl searches intron sequences for the presence of possible cryptic exons. Finally, TRANSSPLICING1.pl and TRANSSPLICING2.pl screens ESTs for those in which the two ends correspond to different genes.
It took five days for a desktop computer (AMD Athlon 2200+ processor) to run this program pipeline to get the final results.
RESULTS AND DISCUSSION
Stage I screening for ExScram and ExRep
In order to detect and characterize exon scrambling (ExScram) and exon repetition (ExRep) events in ESTs, we developed a program package, SCRAMBLING, for comparison of all currently-available human EST sequences (5,992,495) with the entire set of 20,342 human intron-containing genes. SCRAMBLING begins computations from establishing a correspondence between each EST sequence and the gene it was produced from. As a result, 3,221,193 ESTs were linked unambiguously with their native genes. Next, we mapped the beginning and end of each EST onto the corresponding mRNA sequence and calculated the length of the mRNA fragment between these two mapped positions. If the length of this mRNA fragment differed from the length of EST sequence by over 40 nucleotides, that EST was processed further to test for possible ExScram and ExRep events. The threshold of 40 nucleotides is high enough to discard all small variations in length due to inaccuracy of EST sequencing as well as most of the cases of alternative splicing with alternative usage of nearby 5`-or 3`-splice sites. At the same time, the 40-nucleotide threshold is relatively low in comparison to the average human exon length (125 nt). So the vast majority of known cases of ExScram and ExRep would exceed this threshold. When we obtained several mapping positions of EST termini onto corresponding mRNA (due to exon duplication or repetitive segments within mRNA), we considered all possible combinations between mapped EST beginnings and ends. There were a total of 182,100 EST sequences that passed this initial selection (see Table 1 ).
Stage II screening for ExScram and ExRep
The next computational procedure of SCRAMBLING pipeline was designed to distinguish possible ExScram and ExRep events from alternative splicing, which represent the vast majority of the selected 182,100 ESTs.
In order to find putative ExRep, the candidate EST sequence was compared with exon sequences of the corresponding gene to generate a series of identity scores showing the proportion of each exon that was present in the EST. (If the entire exon was present the score was 1.0; if a half of exon was present the score was 0.5; etc.) For this purpose, the individual exon sequences were taken from the exon-only form of EID (file hs35p1.exEID), which is described in Materials and Methods. During this procedure, putative ExRep cases were selected when the identity score for one of the exons was greater than 1.2.
In order to find putative ExScram events, the candidate EST sequence was compared to exon sequences of the corresponding gene to determine the order of exons along the EST. For example, if the program outputs (2,3,4,5,6) it means that the beginning of the EST is represented by the second exon following by the third through sixth exons in order. When the program generates an abnormal order of exons (for instance, the order (1,2,4,5,6,3,4,5) for EST sequence AU118844 shown in Figure 3a ) such cases were designated as putative ExScram events.
The EST candidates selected so far for ExRep and ExScram could have a special arrangement of their exonic sequences due to alternative splicing. For example, putative repetitive or scrambling exons could be alternatively spliced cryptic exons located within introns. Therefore, to exclude the possibility of alternative splicing among the selected ESTs, we compared them with all intronic sequences from their genes. For these computations, intron sequences were taken for the intron-only form of EID (dataset hs35p1.intrEID). 
Stage III screening for ExScram and ExRep
Further characterization of the 401 putative ExRep and 416 putative ExScram candidates was performed by individually aligning the ESTs with their corresponding mRNA and genomic sequences, using BLAST alignment for two sequences (bl2seq) with the help of in-house Perl-scripts designed for automation of this examination. The majority of the 401 ExRep candidates represent cases when repetition occurs only with a portion of and not the whole exon. Thus, we refer to such cases as partial ExRep. Over half of the partial ExRep cases had the repeated exonic sequence bordered by direct 3-12 nt repeats. A typical instance of partial ExRep is demonstrated in Figure 1 , where short DNA repeats bordering the duplicated exonic segment are indicated by arrows. We detected repetition of an entire exonic sequence in only 18 cases, as described in Table 2 . The first eleven ESTs from Table 2 represent convincing instances of ExRep and their structures are further illustrated in Figure 2 . The remaining seven cases from the bottom of Table 2 represent artificial mRNA constructs that were obtained from the RAGE library (Harrington et al. 2001 ), or resulted due to an exon amplification technique (Church et al. 1994) . Therefore, we do not consider these seven instances as real ExRep events. It is evident from Table 2 and Figure 2 , that detected ExRep i) do not have a strong tendency to be at a specific position inside the gene (both 5`-and 3`-end locations are possible) and ii) individual exons as well as exon pairs can undergo repetition. The described ESTs with whole-exon repetition were thoroughly investigated for alternative explanations of this phenomenon. For this purpose, we examined 500,000 nt long sequences from GenBank upstream and downstream from these eight genes in the presence of their duplicated copies or alternative promoters that could generate mRNA with an ExRep-like structure. All intron sequences inside these genes were carefully examined. We could find no evidence for alternative interpretations of the whole ExRep cases from Figure 2 . However, we cannot rule out the possibility that the observed EST abnormalities with whole ExRep are due to errors in the human genome sequence assembly (Istrail et al. 2004; She et al. 2004 ). If we initially worked with a subset of erroneous human gene sequences, the abnormalities in their products would be an expected consequence. Another alternative explanation of observed ExRep could be allele-specific exon duplications that occurred in the tissues from which the ESTs were obtained. It is known that exon duplication is a very common genomic process that has produced about 10% of human exons (Fedorov et al. 1998; Kondrashov and Koonin 2001; Letunic et al. 2002) . Therefore, it is possible that some of these reported whole ExRep cases are due to unknown exon duplication events.
After investigation of the 416 EST candidates with putative ExScram we found no cases of scrambling that occurred with an entire exon but only with exonic pieces. In half of these ExScram cases we consistently saw short direct (3-12 nt) DNA repeats bordering the scrambling sequence (the same structures we detected for ExRep events). Two typical examples of such partial ExScram are demonstrated in Figure 3 . We speculate that the observed partial ExRep and ExScram could occur during experimental procedures of EST cloning such as polymerase slippage during reverse transcription (Zhang et al. 2001) or DNA rearrangements within some intrinsically unstable cDNA fragments. Because we could not detect even one example of entire exon scrambling among 3.2 million ESTs, it seems unlikely that exon scrambling occurs normally in human cells. Several cases of exon scrambling that have been previously reported in the literature may have occurred through other means such as experimental procedures during cDNA generation.
Computer search for trans-splicing
In order to find trans-splicing among 5,992,495 human ESTs, we employed TRANSSPLICING1.pl and TRANSSPLICING1.pl programs. In these computations we initially selected 253,838 ESTs in which the 5`-and 3`-ends corresponded to different human genes. During this selection we also required that two genes, having sequences present in the same EST, should not have adjacent positions within the same chromosomal locus (in our algorithm they had to be separated by at least 30 other genes). This constraint was designed to avoid false positive results from alternative distal promoters (alternative 5`-exons). Example cases of long transcription across neighboring genes are described by Romani and co-authors in their computational search for TransSpl in mRNA sequences in GenBank (Romani et al. 2003) . Then, at the next cycle of selection, we required that at least two independent ESTs should represent the same putative trans-splicing event (ends of ESTs must be represented by the same pair of genes and also have the same junction site for putative TransSpl). The rationale for this filtering is to eliminate false-positive cases due to ligation of two random cDNA sequences or other experimental procedures that could occur in the process of EST cloning. As a result of this selection, we narrowed our sample to 2,014 putative cases of TransSpl. Among these selected ESTs, many candidates for TransSpl were represented by gene pairs having very similar sequences. After excluding cases with the program that searches for 20-nt long identical fragments in gene pairs, we had 972 cases left. Further investigation of these 972 putative TransSpl events was done individually with the help of short Perl scripts to automate the screening process. A vast majority of these candidates for TransSpl appeared to be false-positive due to DNA-repetitive elements inside mRNAs (Alu-repeats, mini-satellites, etc). The removal of all EST candidates with repetitive elements resulted in the identification of 15 ESTs that represented five different cases of putative TransSpl (see Table 1 ). Among the final set of 15 candidates, six independent ESTs (BM555536, BM809442, BM811153, BM913457, BM914863, and BG491331) were represented by the sequences of the phosphomannomutase-2 gene (NP_000294) on chromosome 16 and the farnesyl diphosphate synthase gene (NP_001995) on chromosome 1 (Figure 4a ). The 5`-ends of these six ESTs are identical to the first seven exons of the phosphomannomutase-2 gene, while the 3`-ends of the ESTs correspond to the 4 th --7 th exons of the farnesyl diphosphate synthase gene. Remarkably, all these six ESTs were obtained in the same laboratory from the same tissue (amelanotic melanoma) according to the feature table of their GenBank records. Hence, there is a possible trivial explanation for this phenomenon other than TransSpl. Since genomic rearrangement frequently occurs in cancer tissues (Rabbitts 1994) , we propose that chromosomal recombination occurred de novo in the amelanotic melanoma cells which brought together the loci of the phosphomannomutase-2 and farnesyl diphosphate synthase genes. Therefore, the detected six ESTs likely represent the product of a novel human fusion gene.
The remaining four cases with putative TransSpl occurred between the following genes: 1) synaptophysin and tetraspanin 7 (EST: BI599645 and BI602014; Figure 4b) ; 2) MHC DP alpha 1 precursor and myeloid/lymphoid or mixed-lineage leukemia 2 (EST: BF931318 and BF931405); 3) procollagen type II alpha 1 and GABA(A) receptorassociated protein (EST: BE813120 and BF326430); 4) GDP dissociation inhibitor 2 and ribosomal protein L3 (EST: BQ349883, BQ350058, and BQ350484). All four of these cases with putative TransSpl have the following characteristics as shown in Figure 4b : 1) ESTs were obtained by the same laboratory from the same cancer tissue; 2) junctions for the putative trans-splicing occurs in the middle of exons. Therefore, none of these cases could be considered as real trans-splicing events beyond reasonable doubt. These data demonstrate that our computational procedures function well, yet TransSpl, with even minimal reproducibility, is not detectable among 3.2 million ESTs. Our results for bioinformatic investigation of TransSpl are consistent with the previous smaller-scale study on the same subject by Romani and co-authors (Romani et al. 2003) . Despite the fact that a percentage of publicly available EST and mRNA sequences have chimeric structures, the vast majority of these chimers are the artifact of the cDNA construction process. The occurrences of intriguing reproducible chimeric mRNAs represent either chromosomal translocations identified in cancer cells, or long transcription events across neighboring genes.
We found that whole-exon repetition is an extremely rare process that was detected eleven times among 3.2 million human EST molecules from different tissues and cellular conditions. The whole-exon scrambling splicing event is even more elusive, if it exists at all (0 cases of whole ExScram among 3.2 million ESTs).
When rearrangements occurred with exon pieces, ESTs with partial ExRep-and ExScram-like structures, were detected in 0.023% of the studied sequences. However, alternative explanations such as cDNA rearrangements or reverse polymerase slippage could explain these sequencing abnormalities.
Reproducible cases of trans-splicing that occurred with at least two independent ESTs have not been detected among 3.2 million human mRNA molecules. All fifteen ESTs with TransSpl-like structures were detected in cancer cells and probably appeared due to genomic rearrangements. For example, we found the origin of a novel human gene in a amelanotic melanoma by recombining the 5`-end of the phosphomannomutase 2 gene and the 3`-end of the farnesyl diphosphate synthase gene. Therefore, even though TransSpl may occur, it is extremely rare and not plays an important role in humans. A -EST AU118844 representing Hypoxia-inducible factor 3 gene. Short 3-bp direct repeat inside exon 2 and exon 4 showed as black arrow is CAG. 7-bp direct repeat inside exon 3 and exon 6 showed as white arrow is GGGAGTG. B -EST CO245739 representing Nodal modulator 2 gene. 12-bp direct repeat inside exon 12 and exon 17 showed as black arrow is TACAAAGTGCAG. Scheme of putative trans-splicing events found in ESTs. The first two rows represent structure of the genes which sequences were found within EST candidates for TransSpl. The exonic sequences presented in EST are shown in color, while exonic sequences that are absent in EST are shown as white boxes. Bottom row represents structure of EST sequences. A -ESTs (BM555536, BM809442, BM811153, BM913457, BM914863, and BG491331); B -ESTs BI599645 and BI602014; 
